Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques

被引:80
作者
Zhang, LQ
Dailey, PJ
He, T
Gettie, A
Bonhoeffer, S
Perelson, AS
Ho, DD
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
[2] Chiron Corp, Emeryville, CA 94608 USA
[3] Univ Oxford, Dept Zool, Oxford OX1 3PS, England
[4] ETH Zurich, Expt Ecol, Zurich, Switzerland
[5] Univ Calif Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA
关键词
D O I
10.1128/JVI.73.1.855-860.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Perturbation of the equilibrium between human immunodeficiency virus type 1 (HIV-1) and the infected host by administering antiretroviral agents has revealed the rapid turnover of both viral particles and productively infected cells. In this study, we used the infusion of simian immunodeficiency virus (SIV) particles into rhesus macaques to obtain a more accurate estimate of viral clearance in vivo. Consistently, exogenously infused virions were cleared from plasma with an extremely short half-life, on the order of minutes (a mean of 3.3 min). This new estimate is similar to 100-fold lower than the upper bound of 6 h previously reported for HIV-1 in infected humans. In select animals, multiple tissues were collected at the completion of each experiment to track the potential sites of virion clearance. Detectable levels of SIV RNA were found in lymph nodes, spleen, lungs, and liver, but not in other tissues examined. However, only similar to 1 to 10% or less of the infused virions were accounted for by the thorough tissue sampling, indicating that the vast majority of the infused particles must have been degraded over a short period of time. Should the rapid clearance of virions described here be applicable to infected patients, then HIV-I production and thus the number of productively infected CD4(+) T lymphocytes or the viral burst size must be proportionally higher than previous minimal estimates.
引用
收藏
页码:855 / 860
页数:6
相关论文
共 30 条
[1]   HUMAN-IMMUNODEFICIENCY-VIRUS CAUSES MONONUCLEAR PHAGOCYTE DYSFUNCTION [J].
BALDWIN, GC ;
FLEISCHMANN, J ;
CHUNG, YG ;
KOYANAGI, Y ;
CHEN, ISY ;
GOLDE, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) :3933-3937
[2]  
BENDER BS, 1988, REV INFECT DIS, V10, P1142
[3]   METHODS FOR CHARACTERIZATION OF NUCLEIC ACIDS BY BASE COMPOSITION [J].
BENDICH, A .
METHODS IN ENZYMOLOGY, 1957, 3 :715-723
[4]  
BRUNNER KT, 1960, J IMMUNOL, V85, P99
[5]  
Cavert W, 1997, SCIENCE, V276, P1321
[6]   Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection [J].
Cavert, W ;
Notermans, DW ;
Staskus, K ;
Wietgrefe, SW ;
Zupancic, M ;
Gebhard, K ;
Henry, K ;
Zhang, ZQ ;
Mills, R ;
McDade, H ;
Goudsmit, J ;
Danner, SA ;
Haase, AT .
SCIENCE, 1997, 276 (5314) :960-964
[7]   Dynamics of HIV-1 replication in vivo [J].
Ho, DD .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (11) :2565-2567
[8]   RAPID TURNOVER OF PLASMA VIRIONS AND CD4 LYMPHOCYTES IN HIV-1 INFECTION [J].
HO, DD ;
NEUMANN, AU ;
PERELSON, AS ;
CHEN, W ;
LEONARD, JM ;
MARKOWITZ, M .
NATURE, 1995, 373 (6510) :123-126
[9]  
MIMS CA, 1959, BRIT J EXP PATHOL, V40, P533
[10]  
MIMS CA, 1956, BRIT J EXP PATHOL, V37, P110